English

Cardiogenesis Corp /CA

EDGAR

Quarterly report (10-Q) · filed 2011-05-16

75 filing records in this dataset, filed from 1996-08-13 to 2011-05-16. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

3.05 million USD

2011-03-31 · USD

Exact inputs and evidence

Revenue: 3053000 USD Source

Operating margin

-14.05%

2011-03-31 · %

Exact inputs and evidence

Operating Income: -429000 USD Source
Revenue: 3053000 USD Source

Operating cash flow

-584 thousand USD

2011-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -584000 USD Source

Free cash flow

-598 thousand USD

2011-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -584000 USD Source
Capital Expenditure: 14000 USD Source

Cash and cash equivalents: 1.15 million USD 2011-03-31 Source
Exact value

1147000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2011-05-16.

Financial data available through: 2000-12-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2000-12-31
Operating income: 6 of 11 periods available· newest 2000-12-31
Net income: 6 of 11 periods available· newest 2000-12-31
Operating cash flow: 1 of 11 periods available· newest 2000-12-31
Capital expenditure: 1 of 11 periods available· newest 2000-12-31
Total assets: 5 of 11 periods available· newest 2000-12-31
Total liabilities: 5 of 11 periods available· newest 2000-12-31
Current assets: 5 of 11 periods available· newest 2000-12-31
Current liabilities: 5 of 11 periods available· newest 2000-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 2000-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-12.3%

Prior period

USD 25.32 million

1999-01-01 – 1999-12-31
Current period

USD 22.21 million

2000-01-01 – 2000-12-31

Exact inputs and evidence

22210000 − 25324000 = -3114000 USD

25324000 USD · 1999-01-01 – 1999-12-31
Inspect prior input Prior source
22210000 USD · 2000-01-01 – 2000-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Cardiogenesis Corp /CA · 2000-12-31 Cardiogenesis Corp /CA (edgar:863680) Year-over-year change in Revenue: -3114000 USD Concept: fundies:Revenue Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/863680?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 22210000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/863680/0000950005-01-000443.txt#2843 Input fundies:Revenue: 25324000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/863680/0000950005-01-000443.txt#2843
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 13.72 million

Prior period

−USD 28.33 million

1999-01-01 – 1999-12-31
Current period

−USD 14.61 million

2000-01-01 – 2000-12-31

Exact inputs and evidence

-14609000 − -28333000 = 13724000 USD

-28333000 USD · 1999-01-01 – 1999-12-31
Inspect prior input Prior source
-14609000 USD · 2000-01-01 – 2000-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Cardiogenesis Corp /CA · 2000-12-31 Cardiogenesis Corp /CA (edgar:863680) Year-over-year change in Net income: 13724000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/863680?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -14609000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/863680/0000950005-01-000443.txt#3022 Input fundies:NetIncome: -28333000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/863680/0000950005-01-000443.txt#2861
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Operating cash flow, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2000 2000-01-01 – 2000-12-31

Revenue USD 22.21 million 100% of revenue
Cost of revenue USD 10.06 million 45% of revenue
Operating expenses USD 27.07 million 122% of revenue
Operating income −USD 14.92 million −67% of revenue
Tax, interest and other Derived −USD 310,000 −1.4% of revenue
Net income −USD 14.61 million −66% of revenue

Cash

Operating cash flow −USD 12.28 million −55% of revenue
Capital expenditure USD 762,000 3.4% of revenue
Free cash flow Derived −USD 13.04 million −59% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1994 Operating loss: operating costs were 177% of revenue.
1995 Operating loss: operating costs were 156% of revenue.
1996 Operating loss: operating costs were 159% of revenue.
1998 Operating loss: operating costs were 439% of revenue.
1999 Operating loss: operating costs were 215% of revenue.
2000 Operating loss: operating costs were 167% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1994 1994-01-01 – 1994-12-31	2020000	3567000 Derived	-1547000	435000 Derived	-1982000	Unavailable	Source 1994-01-01 – 1994-12-31: 2020000 USD Inspect Revenue Open source 1994-01-01 – 1994-12-31: -1547000 USD Inspect Operating Income Open source 1994-01-01 – 1994-12-31: -1982000 USD Inspect Net Income Open source
1995 1995-01-01 – 1995-12-31	2707000	4212000 Derived	-1505000	921000 Derived	-2426000	Unavailable	Source 1995-01-01 – 1995-12-31: 2707000 USD Inspect Revenue Open source 1995-01-01 – 1995-12-31: -1505000 USD Inspect Operating Income Open source 1995-01-01 – 1995-12-31: -2426000 USD Inspect Net Income Open source
1996 1996-01-01 – 1996-12-31	9759000	15471000 Derived	-5712000	-1556000 Derived	-4156000	Unavailable	Source 1996-01-01 – 1996-12-31: 9759000 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: -5712000 USD Inspect Operating Income Open source 1996-01-01 – 1996-12-31: -4156000 USD Inspect Net Income Open source
1998 1998-01-01 – 1998-12-31	15080000	66213000 Derived	-51133000	-3366000 Derived	-47767000	Unavailable	Source 1998-01-01 – 1998-12-31: 15080000 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -51133000 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: -47767000 USD Inspect Net Income Open source
1999 1999-01-01 – 1999-12-31	25324000	54394000 Derived	-29070000	-737000 Derived	-28333000	Unavailable	Source 1999-01-01 – 1999-12-31: 25324000 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -29070000 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -28333000 USD Inspect Net Income Open source
2000 2000-01-01 – 2000-12-31	22210000	37129000 Derived	-14919000	-310000 Derived	-14609000	-13043000 Derived	Source 2000-01-01 – 2000-12-31: 22210000 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -14919000 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -14609000 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -12281000 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 762000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 22.2M 2000

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Revenue	2020000	Revenue: 2020000 Open source
19951995-12-31	Revenue	2707000	Revenue: 2707000 Open source
19961996-12-31	Revenue	9759000	Revenue: 9759000 Open source
19981998-12-31	Revenue	15080000	Revenue: 15080000 Open source
19991999-12-31	Revenue	25324000	Revenue: 25324000 Open source
20002000-12-31	Revenue	22210000	Revenue: 22210000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-12.3% 2000

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19941994-12-31	Year over year	No prior comparable period	Revenue: 2020000 Open source
19951995-12-31	Year over year	34%	Revenue: 2707000 Open source Revenue: 2020000 Open source
19961996-12-31	Year over year	260.5%	Revenue: 9759000 Open source Revenue: 2707000 Open source
19981998-12-31	Year over year	No prior comparable period	Revenue: 15080000 Open source
19991999-12-31	Year over year	67.9%	Revenue: 25324000 Open source Revenue: 15080000 Open source
20002000-12-31	Year over year	-12.3%	Revenue: 22210000 Open source Revenue: 25324000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -67.2% 2000

Net margin -65.8% 2000

Free cash flow margin -58.7% 2000

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19941994-12-31	Operating margin	-76.6%	Operating Income: -1547000 Open source Revenue: 2020000 Open source
19951995-12-31	Operating margin	-55.6%	Operating Income: -1505000 Open source Revenue: 2707000 Open source
19961996-12-31	Operating margin	-58.5%	Operating Income: -5712000 Open source Revenue: 9759000 Open source
19981998-12-31	Operating margin	-339.1%	Operating Income: -51133000 Open source Revenue: 15080000 Open source
19991999-12-31	Operating margin	-114.8%	Operating Income: -29070000 Open source Revenue: 25324000 Open source
20002000-12-31	Operating margin	-67.2%	Operating Income: -14919000 Open source Revenue: 22210000 Open source
19941994-12-31	Net margin	-98.1%	Net Income: -1982000 Open source Revenue: 2020000 Open source
19951995-12-31	Net margin	-89.6%	Net Income: -2426000 Open source Revenue: 2707000 Open source
19961996-12-31	Net margin	-42.6%	Net Income: -4156000 Open source Revenue: 9759000 Open source
19981998-12-31	Net margin	-316.8%	Net Income: -47767000 Open source Revenue: 15080000 Open source
19991999-12-31	Net margin	-111.9%	Net Income: -28333000 Open source Revenue: 25324000 Open source
20002000-12-31	Net margin	-65.8%	Net Income: -14609000 Open source Revenue: 22210000 Open source
19941994-12-31	Free cash flow margin	Not reported	Revenue: 2020000 Open source
19951995-12-31	Free cash flow margin	Not reported	Revenue: 2707000 Open source
19961996-12-31	Free cash flow margin	Not reported	Revenue: 9759000 Open source
19981998-12-31	Free cash flow margin	Not reported	Revenue: 15080000 Open source
19991999-12-31	Free cash flow margin	Not reported	Revenue: 25324000 Open source
20002000-12-31	Free cash flow margin	-58.7%	Revenue: 22210000 Open source Operating Cash Flow: -12281000 Open source Capital Expenditure: 762000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -12.3M 2000

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Operating cash flow	Not reported	No source recorded
19951995-12-31	Operating cash flow	Not reported	No source recorded
19961996-12-31	Operating cash flow	Not reported	No source recorded
19981998-12-31	Operating cash flow	Not reported	No source recorded
19991999-12-31	Operating cash flow	Not reported	No source recorded
20002000-12-31	Operating cash flow	-12281000	Operating Cash Flow: -12281000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -13M 2000

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-12-31	Free cash flow	Unavailable	No source recorded
19951995-12-31	Free cash flow	Unavailable	No source recorded
19961996-12-31	Free cash flow	Unavailable	No source recorded
19981998-12-31	Free cash flow	Unavailable	No source recorded
19991999-12-31	Free cash flow	Unavailable	No source recorded
20002000-12-31	Free cash flow	-13043000	Operating Cash Flow: -12281000 Open source Capital Expenditure: 762000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

53% 2000

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1994-12-31	Liabilities / assets	Not reported	No source recorded
19951995-12-31	Liabilities / assets	158.1%	Total Liabilities: 3888000 Open source Total Assets: 2459000 Open source
19961996-12-31	Liabilities / assets	5.2%	Total Liabilities: 3040000 Open source Total Assets: 58706000 Open source
19981998-12-31	Liabilities / assets	29.6%	Total Liabilities: 15702000 Open source Total Assets: 52978000 Open source
19991999-12-31	Liabilities / assets	45.4%	Total Liabilities: 15446000 Open source Total Assets: 34019000 Open source
20002000-12-31	Liabilities / assets	53%	Total Liabilities: 8991000 Open source Total Assets: 16965000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.54× 2000

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1994-12-31	Current assets / current liabilities	Not reported	No source recorded
19951995-12-31	Current assets / current liabilities	0.6×	Current Assets: 2339000 Open source Current Liabilities: 3888000 Open source
19961996-12-31	Current assets / current liabilities	16.85×	Current Assets: 50881000 Open source Current Liabilities: 3020000 Open source
19981998-12-31	Current assets / current liabilities	2.43×	Current Assets: 37831000 Open source Current Liabilities: 15588000 Open source
19991999-12-31	Current assets / current liabilities	1.69×	Current Assets: 24662000 Open source Current Liabilities: 14631000 Open source
20002000-12-31	Current assets / current liabilities	1.54×	Current Assets: 13248000 Open source Current Liabilities: 8586000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1994 1994-01-01 – 1994-12-31	−USD 1.98 million Exact value Exact value: -1982000 USD 1994-01-01 – 1994-12-31: -1982000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Cardiogenesis Corp /CA · 1994-12-31 Cardiogenesis Corp /CA (edgar:863680) Net Income: -1982000 USD Concept: fundies:NetIncome Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/863680/explain?concept=fundies%3ANetIncome&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1982000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/863680/0000912057-97-009994.txt#2299 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
1995 1995-01-01 – 1995-12-31	−USD 2.43 million Exact value Exact value: -2426000 USD 1995-01-01 – 1995-12-31: -2426000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Cardiogenesis Corp /CA · 1995-12-31 Cardiogenesis Corp /CA (edgar:863680) Net Income: -2426000 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/863680/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2426000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/863680/0000912057-97-009994.txt#2299 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
1996 1996-01-01 – 1996-12-31	−USD 4.16 million Exact value Exact value: -4156000 USD 1996-01-01 – 1996-12-31: -4156000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Cardiogenesis Corp /CA · 1996-12-31 Cardiogenesis Corp /CA (edgar:863680) Net Income: -4156000 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/863680/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4156000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/863680/0000912057-97-009994.txt#2299 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
1998 1998-01-01 – 1998-12-31	−USD 47.77 million Exact value Exact value: -47767000 USD 1998-01-01 – 1998-12-31: -47767000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Cardiogenesis Corp /CA · 1998-12-31 Cardiogenesis Corp /CA (edgar:863680) Net Income: -47767000 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/863680/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -47767000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/863680/0000950005-01-000443.txt#2861 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
1999 1999-01-01 – 1999-12-31	−USD 28.33 million Exact value Exact value: -28333000 USD 1999-01-01 – 1999-12-31: -28333000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Cardiogenesis Corp /CA · 1999-12-31 Cardiogenesis Corp /CA (edgar:863680) Net Income: -28333000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/863680/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -28333000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/863680/0000950005-01-000443.txt#2861 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2000 2000-01-01 – 2000-12-31	−USD 14.61 million Exact value Exact value: -14609000 USD 2000-01-01 – 2000-12-31: -14609000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Cardiogenesis Corp /CA · 2000-12-31 Cardiogenesis Corp /CA (edgar:863680) Net Income: -14609000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/863680/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -14609000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/863680/0000950005-01-000443.txt#3022 The citation records this snapshot. The page link may show a newer release later.	−USD 12.28 million Exact value Exact value: -12281000 USD 2000-01-01 – 2000-12-31: -12281000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Cardiogenesis Corp /CA · 2000-12-31 Cardiogenesis Corp /CA (edgar:863680) Operating Cash Flow: -12281000 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/863680/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12281000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/863680/0000950005-01-000443.txt#3045 The citation records this snapshot. The page link may show a newer release later.	USD 762,000 Exact value Exact value: 762000 USD 2000-01-01 – 2000-12-31: 762000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Cardiogenesis Corp /CA · 2000-12-31 Cardiogenesis Corp /CA (edgar:863680) Capital Expenditure: 762000 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/863680/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 762000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/863680/0000950005-01-000443.txt#3050 The citation records this snapshot. The page link may show a newer release later.	−USD 13.04 million Calculation and evidence -12281000 − 762000 USD Exact free cash flow: -13043000 USD 2000-01-01 – 2000-12-31: -12281000 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 762000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Cardiogenesis Corp /CA · 2000-12-31 Cardiogenesis Corp /CA (edgar:863680) Free cash flow: -13043000 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/863680?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12281000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/863680/0000950005-01-000443.txt#3045 Input fundies:CapitalExpenditure: 762000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/863680/0000950005-01-000443.txt#3050 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

75 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000863680, 863680, edgar:863680

Also known as CARDIOGENESIS CORP /CA, ECLIPSE SURGICAL TECHNOLOGIES INC

Cardiogenesis Corp /CA

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Where revenue goes

2000 2000-01-01 – 2000-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation